UMIN-ICDS Clinical Trial

Unique ID issued by UMIN UMIN000060192
Receipt number R000068848
Scientific Title Effects of Far-Infrared Blood Circulation Promotion Devices on Sleep Quality
Date of disclosure of the study information 2026/10/01
Last modified on 2026/07/18 15:14:22

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Effects of Far-Infrared Blood Circulation Promotion Devices on Sleep Quality

Acronym

Effects of Far-Infrared Blood Circulation Promotion Devices on Sleep Quality

Scientific Title

Effects of Far-Infrared Blood Circulation Promotion Devices on Sleep Quality

Scientific Title:Acronym

Effects of Far-Infrared Blood Circulation Promotion Devices on Sleep Quality

Region

Japan


Condition

Condition

People who complaining of sleep disorders

Classification by specialty

Medicine in general

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To investigate the effects of bedding using far-infrared-based fibers on sleep quality and metabolism in people who complaining of sleep disorders

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Changes in the sum of deep sleep and REM sleep

Key secondary outcomes

Differences in sleep-related items other than primary endpoint
Difference in change in Athens Insomnia Scale score
Difference in change in SPQ scores
Difference in change in nocturnal heart rate variability


Base

Study type

Interventional


Study design

Basic design

Cross-over

Randomization

Randomized

Randomization unit

Individual

Blinding

Double blind -all involved are blinded

Control

Placebo

Stratification

YES

Dynamic allocation

NO

Institution consideration


Blocking

YES

Concealment

Central registration


Intervention

No. of arms

2

Purpose of intervention

Prevention

Type of intervention

Other

Interventions/Control_1

Bedding with Far-Infrared Fibers

Interventions/Control_2

Bedding without far-infrared fibers

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

18 years-old <=

Age-upper limit

70 years-old >

Gender

Male and Female

Key inclusion criteria

People who are worked at Matsushita Memorial Hospital
People from whom written informed consent to participate in the study can be obtained voluntarily
People with scoring 4 points or higher on the Athens Insomnia Scale
People aged 18 years or older but under 70 years at the time of consent acquisition

Key exclusion criteria

People who had acute infectious diseases, malignant diseases, heart disease, and other conditions requiring acute-phase treatment
Women with pregnancy

Target sample size

30


Research contact person

Name of lead principal investigator

1st name Yoshitaka
Middle name
Last name Hashimoto

Organization

Matsushita Memorial Hospital

Division name

Department of Diabetes and Endocrinology

Zip code

570-8540

Address

5-55 Sotojima-cho, Moriguchi 570-8540, Japan

TEL

0669921231

Email

y-hashi@koto.kpu-m.ac.jp


Public contact

Name of contact person

1st name Mayumi
Middle name
Last name Sugimoto

Organization

Matsushita Memorial Hospital

Division name

Department of medical records

Zip code

570-8540

Address

5-55 Sotojima-cho, Moriguchi 570-8540, Japan

TEL

0669921231

Homepage URL


Email

sugimoto.mayumi@jp.panasonic.com


Sponsor or person

Institute

Matsushita Memorial Hospital

Institute

Department

Personal name



Funding Source

Organization

TOYOSHIMA & Co.,Ltd.

Organization

Division

Category of Funding Organization

Profit organization

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Matsushita Memorial Hospital

Address

5-55 Sotojima-cho, Moriguchi 570-8540, Japan

Tel

0669921231

Email

sugimoto.mayumi@jp.panasonic.com


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2026 Year 10 Month 01 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

No longer recruiting

Date of protocol fixation

2025 Year 11 Month 15 Day

Date of IRB

2025 Year 11 Month 27 Day

Anticipated trial start date

2025 Year 12 Month 15 Day

Last follow-up date

2026 Year 05 Month 01 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2025 Year 12 Month 24 Day

Last modified on

2026 Year 07 Month 18 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000068848